4//SEC Filing
Tobira Therapeutics, Inc. 4
Accession 0001140361-16-080939
CIK 0001311596operating
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:00 PM ET
Size
6.9 KB
Accession
0001140361-16-080939
Insider Transaction Report
Form 4
Pentwater Capital Management LP
10% Owner
Transactions
- Purchase
Common Stock, par value $0.001 per share
2016-09-26$39.00/sh+49,400$1,926,600→ 3,683,200 total(indirect: By managed account) - Purchase
Common Stock, par value $0.001 per share
2016-09-26$39.01/sh+600$23,406→ 3,633,800 total(indirect: By managed account)
Footnotes (1)
- [F1]The reporting person is the investment manager for PWCM Master Fund Ltd, an exempted company formed in the Cayman Islands, Pentwater Equity Opportunities Master Fund, Ltd., an exempted company formed in the Cayman Islands, Oceana Master Fund, Ltd., an exempted company formed in the Cayman Islands, Amundi Absolute Return Pentwater Fund Plc, a private fund formed in Ireland, Pentwater Event Driven Cayman Fund Limited, an exempted company formed in the Cayman Islands, Pentwater Merger Arbitrage Master Fund LTD, an exempted company formed in the Cayman Islands, and LMA SPC for and on behalf of MAP 98 Segregated Portfolio, a segregated portfolio company formed in the Cayman Islands, which directly own the shares.
Documents
Issuer
Tobira Therapeutics, Inc.
CIK 0001311596
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311596
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 6:00 PM ET
- Size
- 6.9 KB